1. Roden M and Shulman GI. The integrative biology of type 2 diabetes. Nature. 2019; 576(7785): 51-60; [
DOI:10.1038/s41586-019-1797-8]
2. Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, Song X, Ren Y and Shan P-F. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Sci. Rep. 2020; 10(1): 14790; [
DOI:10.1038/s41598-020-71908-9]
3. Azadnajafabad S, Mohammadi E, Aminorroaya A, Fattahi N, Rezaei S, Haghshenas R, Rezaei N, Naderimagham Sh, Larijani B and Farzadfar F. Non-communicable diseases' risk factors in Iran; a review of the present status and action plans. J. Diabetes Metab. Disord. 2021; 23(2): 1-9; [
DOI:10.1007/s40200-020-00709-8]
4. Mezil SA and Abed BA. Complication of diabetes mellitus. Annals of the Romanian Society for Cell Biology. 2021; 25(3): 1546-56.
5. Wang Y, Li W, Peng W, Zhpu J and Liu Z. Acupuncture for postherpetic neuralgia: Systematic review and meta-analysis. Medicine. 2018; 97(34): e11986. [
DOI:10.1097/MD.0000000000011986]
6. Visser NA, Notermans NC, Linssen RS, van den Berg LH and Vrancken AFJE. Incidence of polyneuropathy in Utrecht, the Netherlands. Neurol. 2015; 84(3), 259-264; [
DOI:10.1212/WNL.0000000000001160]
7. Hanewinckel R, Drenthen J, Oijenet M, Hofman A, van Doorn PA and Ikram MA. Prevalence of polyneuropathy in the general middle-aged and elderly population. Neurol. 2016; 87(18): 1892-1898. [
DOI:10.1212/WNL.0000000000003293]
8. Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, Kalso EA, Loeser JD, Miaskowski C, Nurmikko TJ, Portenoy RK, Rice ASC, Stacey BR, Treede R-D, Turk DC and Wallace MS. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain. 2007; 5; 132(3): 237-51. [
DOI:10.1016/j.pain.2007.08.033]
9. Backonja MM and Stacey B. Neuropathic pain symptoms relative to overall pain rating. J. Pain. 2004; 5(9): 491-7. [
DOI:10.1016/j.jpain.2004.09.001]
10. Hanewinckel R, van Oijenet M, Arfan Ikram M and van Doorn P. The epidemiology and risk factors of chronic polyneuropathy. Eur. J. Epidemiol. 2016; 31(1): 5-20. [
DOI:10.1007/s10654-015-0094-6]
11. Callaghan BC, Cheng HT, Stables CL, Smith AL and Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012; 11(6): 521-34. [
DOI:10.1016/S1474-4422(12)70065-0]
12. The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes therapy on the development and progression of neuropathy. Ann. Intern. Med. 1995; 122(8): 561-8. [
DOI:10.7326/0003-4819-122-8-199504150-00001]
13. Medagama AB and Bandara R. The use of complementary and alternative medicines (CAMs) in the treatment of diabetes mellitus: is continued use safe and effective? Nutr. J. 2014; 13: 1-9. [
DOI:10.1186/1475-2891-13-102]
14. Saarto T and Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Db. Syst. Rev. 2007; 4: CD005454. [
DOI:10.1002/14651858.CD005454.pub2]
15. Eardley S, Bishop FL, Prescott P, Cardini F, Brinkhaus B, Santos-Rey K, Vas J, von Ammon K, Hegyi G, Dragan S, Uehleke B, Fønnebø V and Lewith G. A systematic literature review of complementary and alternative medicine prevalence in EU. Forsch Komplementmed. 2012; 19 (Suppl. 2): 18-28; [
DOI:10.1159/000342708]
16. Dall'Acqua S, Bolego C, Cignarell A, Gaion RM and Innocenti G. Vasoprotective activity of standardized Achillea Millefolium extract. Phytomedicine. 2011; 18(12): 1031-1036; [
DOI:10.1016/j.phymed.2011.05.005]
17. Li Y, Zhu MC, Zhang ML, Zhang M-L, Wang Y-F, Dong M, Shi Q-W, Huo Ch-H, Sauriol F, Kiyota H, Gu Y-Ch and Cong B. Achillinin B and C, new sesquiterpene dimers isolated from Achillea millefolium. Tetrahedron Lett. 2012; 53(21), 2601-2603. [
DOI:10.1016/j.tetlet.2012.03.039]
18. Ramírez-Espinos JJ, Yolanda Rios M, López-Martínezet S López-Vallejo F, Medina-Franco JK, Paoli P, Camici G, Navarrete-Vázquez G, Ortiz-Andrade R and Estrada-Soto S. Antidiabetic activity of some pentacyclic acid triterpenoids, the role of PTP-1B: In vitro, in silico, and in vivo approaches. Eur. J. Med. Chem. 2011; 46(6): 2243-2251; [
DOI:10.1016/j.ejmech.2011.03.005]
19. Akram M. Minireview on Achillea millefolium Linn. J. Membr. Biol. 2013; 246(9): 661-3. [
DOI:10.1007/s00232-013-9588-x]
20. Chen J, Mangelinckx S, Adams A, Wang Zh-t, Li W-I and De Kimpe N. Natural flavonoids as potential herbal medication for the treatment of diabetes mellitus and its complications. Nat. Prod. Commun. 2015; 10: 187-200. [
DOI:10.1177/1934578X1501000140]
21. Gaikwad S, Krishna Mohan G, Sandhya Rani M. Phytochemicals for diabetes management. Pharm. Crops. 2014; 5: 11-28. [
DOI:10.2174/2210290601405010011]
22. Putta S, Sastry Yarla N, Kumar Kilari E, Surekha C, Aliev G, Divakara MB, Santosh MS, Ramu R, Zameer F, Prasad Mn N, Chintala R, Rao PV, Shiralgi Y and Dhananjaya BL. Therapeutic potentials of triterpenes in diabetes and its associated complications. Curr. Top. Med. Chem. 2016; 16(23): 2532-2542. [
DOI:10.2174/1568026616666160414123343]
23. Zheng Y, Bai L, Zhou Y, Tong R, Zeng M, Li X and Shi J. Polysaccharides from Chinese herbal medicine for anti-diabetes recent advances. Int. J. Biol. Macromol. 2019; 121: 1240-1253. [
DOI:10.1016/j.ijbiomac.2018.10.072]
24. De Souza P, Gasparotto Jr A, Crestani S, Stefanello MEA, Marques MCA, da Silva-Santos JE and Kassuya CAL. Hypotensive mechanism of the extracts and artemetin isolated from Achillea millefolium L. (Asteraceae) in rats. Phytomedicine. 2011; 18(10): 819-25. [
DOI:10.1016/j.phymed.2011.02.005]
25. Vahid S, Dashti-Khavidaki S, Ahmadi F, Amini M and Salehi Surmaghi MH. Effect of herbal medicine Achillea millefolium on plasma nitrite and nitrate levels in patients with chronic kidney disease: A preliminary study. Iran. J. Kidney Dis. 2012; 5(6): 350-4.
26. Karimi A, Niazkar HR, Azar PS, Tutunchi H, Karimi M, Asghariazar V and Kooshki F. Protective effect of hydro-alcoholic extract of Achillea millefolium on renal injury and biochemical factors in streptozotocin-induced diabetic rats. Nutrition & Food Science. 2021; 18; 51(7): 1068-83; [
DOI:10.1108/NFS-11-2020-0437]
27. Chávez-Silva F, Cerón-Romero L, Arias-Durán L, Navarrete-Vázquez G, Almanza-Pérez J, Román-Ramos R, Ramírez-Ávila G, Perea-Arango I, Villalobos-Molina R and Estrada-Soto S. Antidiabetic effect of Achillea millefollium through multitarget interactions: α-glucosidases inhibition, insulin sensitization, and insulin secretagogue activities. J. Ethnopharmacol. 2018; 15(212): 1-7. oi: 10.1016/j.jep.2017.10.005. [
DOI:10.1016/j.jep.2017.10.005]
28. Nasrabadi Z, Rakhshani MH, Ebadi H, Akbarzadeh R. Comparison of the effect of gabapentin and evening primrose oil on peripheral neuropathy pain in patients with type 2 diabetes. Avice. J. Clin Med. 2019; 26(1): 5-11. [
DOI:10.29252/ajcm.26.1.5]
29. Pandis N. Randomization. Part 2: minimization. Am. J. Orthod. Dentofac. Orthop. 2011; 140(6): 902-4; [
DOI:10.1016/j.ajodo.2011.08.016]
30. Barnes J, Anderson LA, Phillipson JD. Herbal Medicines. 2007, Third ed Pharmaceutical Press, London; Grayslake, IL.
31. Ayoobi F, Moghadam-Ahmadi A, Amiri H, Vakilian AR, Heidari M, Farahmand H, Sheikh Fathollahi M, Fatemi I, Shafiei SA, Alahtavakoli M and Shamsizadeh A. Achillea millefolium is beneficial as an add-on therapy in patients with multiple sclerosis: A randomized placebo-controlled clinical trial. Phytomedicine. 2019; 52: 89-97. [
DOI:10.1016/j.phymed.2018.06.017]
32. Herman WH, Pop-Busui R, Braffett BH, Martin CL, Cleary PA, Albers, Feldman EL; DCCT/EDIC Research Group. Use of the Michigan neuropathy screening instrument as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the diabetes control and complications trial/epidemiology of diabetes interventions and complications. Diabet. Med. 2012; 29(7): 937-44. [
DOI:10.1111/j.1464-5491.2012.03644.x]
33. Fateh HR, Madani SP, Heshmat R and Larijani B. Correlation of Michigan neuropathy screening instrument, the United Kingdom screening test, and electrodiagnosis for early detection of diabetic peripheral neuropathy. J. Diabet & Metabolic Disorders. 2015; 15(8). [
DOI:10.1186/s40200-016-0229-7]
34. Sadeghi H, Radmanesh E, Akbartabar Turi M, Mohammadi R and Nazem H. Hypoglycemic effects of Achillea wilhelmsii in normal and streptozotocin-induced diabetic rats. Armaghane Danesh Bimonth. J. 2009; 14(1): 92-9.
35. Akramian Fard M, Moghaddam Ahmadi A, Ayyobi F, Nakisa H, Hadadian Z, Shabani M, Tavakoli MA and Shamsi zadeh A. Effects of Achillea millefolium aqueous extract in a Parkinson's disease model induced by intra-cerebral-ventricular injection of 6-hydroxydopamine in male rats. JSUMS. 2015; 22(1): 36-44.
36. Vazirinejad R, Ayoobi F, Kazemi Arababadi M, Eftekharian MM, Darekordi A, Goudarzvand M, Hassanshahi GhH, Taghavi MM, Nasiri Ahmadabadi B, Kennedy D and Shamsizadeh A. Effect of aqueous extract of Achillea millefolium on the development of experimental autoimmune encephalomyelitis in C57BL/6 mice. Indian J. Pharmacol. 2014; 46(3): 303-8. [
DOI:10.4103/0253-7613.132168]
37. Benedek B, Kopp B and Melzig MF. Achillea millefolium L. sl-Is the anti-inflammatory activity mediated by protease inhibition. J. Ethnopharmacol. 2007; 113(2): 312-7. [
DOI:10.1016/j.jep.2007.06.014]
38. Kbaydet O, Abou-Ela M and Raafat K. Achillea extracts elicit anti-diabetic neuropathic pain by modulating inflammatory cytokines. JTCM. 2024; [
DOI:10.1016/j.jtcme.2024.04.012]
39. Bathaie SZ, Mokarizade N and Shirali S. An overview of the mechanisms of plant ingredients in the treatment of diabetes mellitus. J. Med Plants. 2012; 10; 11(44): 1-24.
40. Cao G, Booth SL, Sadowski JA and Prior RL. Increases in human plasma antioxidant capacity after consumption of controlled diets high in fruit and vegetables. Am. J. Clin. Nutr. 1998; 68(5): 1081-7; [
DOI:10.1093/ajcn/68.5.1081]